International Biotechnology Trust’s Blueprint Medicines BPMC Stock Holding History

International Biotechnology Trust’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1M	Buy	+20,000	New	+$1.07M	0.34%	52
2022 Q3	–	Sell	-985	Closed	-$19.5K	–	72
2022 Q2	$19.5K	Sell	985 -18,515	-95%	-$1.08M	0.2%	66
2022 Q1	$881K	Hold	19,500	–	–	0.2%	57
2021 Q4	$2.09M	Hold	19,500	–	–	0.47%	44
2021 Q3	$2M	Hold	19,500	–	–	0.48%	40
2021 Q2	$1.72M	Hold	19,500	–	–	0.45%	42
2021 Q1	$1.9M	Hold	19,500	–	–	0.5%	32
2020 Q4	$2.19M	Hold	19,500	–	–	0.6%	33
2020 Q3	$1.81M	Buy	19,500 +7,500	+63%	+$578K	0.58%	31
2020 Q2	$918K	Hold	12,000	–	–	0.31%	45
2020 Q1	$700K	Sell	12,000 -5,000	-29%	-$322K	0.32%	43
2019 Q4	$1.36M	Hold	17,000	–	–	0.49%	43
2019 Q3	$1.25M	Hold	17,000	–	–	0.58%	34
2019 Q2	$1.6M	Buy	+17,000	New	+$1.4M	0.59%	41

Other funds holding BPMC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

International Biotechnology Trust's BPMC Position: Q3 2023 in Review

International Biotechnology Trust opened a new position in Blueprint Medicines (BPMC) in Q3 2023: 20,000 shares worth $1M. The stake represents 0.34% of the portfolio and ranks #52 among its holdings. This is a return to the name: International Biotechnology Trust previously reported a position in BPMC as recently as Q2 2022.

International Biotechnology Trust first reported a position in BPMC in Q2 2019 and has held it in 14 quarters since. The position peaked at $2.19M in Q4 2020. 220 funds tracked by Wall St. Rank hold BPMC as of Q3 2023.

International Biotechnology Trust held 20,000 shares of Blueprint Medicines worth $1M as of Q3 2023.
Blueprint Medicines was a new International Biotechnology Trust position in Q3 2023.
Blueprint Medicines made up 0.34% of International Biotechnology Trust's portfolio in Q3 2023, its #52 holding.
International Biotechnology Trust first reported a position in Blueprint Medicines in Q2 2019 and has held it in 14 quarters since.
International Biotechnology Trust's Blueprint Medicines position peaked at $2.19M in Q4 2020.
220 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.